FMR1 and fragile X syndrome: Because the loss of FMRP is the primary cause of FXS, our data suggest that FXS patient’s urine-derived epithelial cells are a viable option in understanding the disease’s underlying molecular mechanisms, potentially leading to therapeutic intervention.